The transcription strategy of bovine adeno-associated virus (B-AAV) combines features of both adeno-associated virus type 2 (AAV2) and type 5 (AAV5)

被引:1
|
作者
Ye, Chaoyang [1 ]
Pintel, David J. [1 ]
机构
[1] Univ Missouri, Sch Med, Dept Mol Microbiol & Immunol, Columbia, MO 65211 USA
关键词
adeno-associated viruses; transcription profile; AAV5; B-AAV; promoter regulation;
D O I
10.1016/j.virol.2007.09.007
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The parvoviruses bovine adeno-associated virus (B-AAV) and adeno-associated vir-us type 5 (AAV5) have similar transcription maps. However, while the AAV5 capsid gene promoter P41 possesses a high basal level in 293 cells, and is further activated only poorly by Rep during adenovirus type 5 (Ad5) infection, the B-AAV P41 promoter has a low basal activity within RepCap constructs in these cells and can be strongly activated by its Rep protein in the presence of Ad5 when a Rep-binding element (RBE) is included in cis at either end of the molecule. These differences are not due to A differences in the intrinsic activating capability of the individual Rep proteins. Both viral promoters contain AP1 and CRE elements that contribute to their basal activity; however, the nature of the B-AAV P41 promoter itself and the surrounding sequences contribute to its relatively lower basal activity. In addition, the B-AAV upstream transcription units themselves also are activated in the presence of Ad5 and Rep. Thus, although the transcription map of B-AAV is much more closely related to AAV5, activation of its promoters is functionally more like the prototype AAV2. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:392 / 402
页数:11
相关论文
共 50 条
  • [1] Methylation Status of the Adeno-Associated Virus Type 2 (AAV2)
    Toth, Renata
    Meszaros, Istvan
    Hueser, Daniela
    Forro, Barbara
    Marton, Szilvia
    Olasz, Ferenc
    Banyai, Krisztian
    Heilbronn, Regine
    Zadori, Zoltan
    [J]. VIRUSES-BASEL, 2019, 11 (01):
  • [2] Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer
    Zabner, J
    Seiler, M
    Walters, R
    Kotin, RM
    Fulgeras, W
    Davidson, BL
    Chiorini, JA
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (08) : 3852 - 3858
  • [3] Integrin αVβ5 is not involved in adeno-associated virus type 2 (AAV2) infection
    Qiu, JM
    Brown, KE
    [J]. VIROLOGY, 1999, 264 (02) : 436 - 440
  • [4] Adeno-Associated Virus Receptor-Binding: Flexible Domains and Alternative Conformations through Cryo-Electron Tomography of Adeno-Associated Virus 2 (AAV2) and AAV5 Complexes
    Hu, Guiqing
    Silveria, Mark A.
    Zane, Grant M.
    Chapman, Michael S.
    Stagg, Scott M.
    [J]. JOURNAL OF VIROLOGY, 2022, 96 (13)
  • [5] Reducing the Risk of Adeno-Associated Virus (AAV) Vector Mobilization with AAV Type 5 Vectors
    Hewitt, F. Curtis
    Li, Chengwen
    Gray, Steven J.
    Cockrell, Shelley
    Washburn, Michael
    Samulski, R. Jude
    [J]. JOURNAL OF VIROLOGY, 2009, 83 (08) : 3919 - 3929
  • [6] Positive and negative effects of adenovirus type 5 helper functions on adeno-associated virus type 5 (AAV5) protein accumulation govern AAV5 virus production
    Nayak, Ramnath
    Pintel, David J.
    [J]. JOURNAL OF VIROLOGY, 2007, 81 (05) : 2205 - 2212
  • [7] Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism
    Wu, P
    Xiao, W
    Conlon, T
    Hughes, J
    Agbandje-McKenna, M
    Ferkol, T
    Flotte, T
    Muzyczka, N
    [J]. JOURNAL OF VIROLOGY, 2000, 74 (18) : 8635 - 8647
  • [8] Integration of adeno-associated virus (AAV) and recombinant AAV vectors
    McCarty, DM
    Young, SM
    Samulski, RJ
    [J]. ANNUAL REVIEW OF GENETICS, 2004, 38 : 819 - 845
  • [9] Adeno-associated virus (AAV) vectors in the CNS
    McCown, TJ
    [J]. CURRENT GENE THERAPY, 2005, 5 (03) : 333 - 338
  • [10] Convection-enhanced delivery of adeno-associated virus Type 2 (AAV2) into the striatum and transport of AAV2 within monkey brain
    Hadaczek, P
    Kohutnicka, M
    Krauze, MT
    Bringas, J
    Pivirotto, P
    Cunningham, J
    Bankiewicz, K
    [J]. HUMAN GENE THERAPY, 2006, 17 (03) : 291 - 302